IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that its management team is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 8:15 a.m. Pacific Time.
Financial
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
BUDAPEST, Hungary, Dec. 30, 2024 /PRNewswire/ — CardioSight, Inc., developer of a revolutionary intravascular visualization and interventional platform, announces the appointment of Niv Ad, M.D., as Chief Medical Officer. Dr. Ad is an internationally renowned leader in cardiothoracic…
CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt
Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company’s financial debt, via their use in the ongoing equitization of the loan contracted with the European Investment Bank, thus reducing the […]
HealthQuest Capital Invests in Royal Health Inc to Accelerate Innovation in Radiology Operational Solutions
WHITE PLAINS, N.Y., Dec. 23, 2024 /PRNewswire/ — Royal Health Inc, a leading provider of advanced radiology software and workflow solutions, today announced the successful close of a minority investment, led by HealthQuest Capital, a leading growth capital firm focused on investing in…
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the second quarter of fiscal year 2025 […]
Balt secures €355 million to refinance its debt and accelerate its growth
PARIS and MONTMORENCY, France, Dec. 20, 2024 (GLOBE NEWSWIRE) — Balt, a global medical device leader in interventional neuroradiology, announces that it has secured €355 million in financing from a group of leading institutional investors and banks to refinance existing debt, accelerate product innovation, expand production capacity, and enhance development of key growth markets.
ŌURA Secures $200 Million in Series D Funding
SAN FRANCISCO–(BUSINESS WIRE)–ŌURA, the company behind Oura Ring, the world’s leading smart ring, today announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 […]
DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care
December 18, 2024 07:35 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced an expanded partnership with SHL Telemedicine (NASDAQ: SHLT) to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. […]
Scott Burger Appointed as CEO of AngioInsight, Inc.
MINNETONKA, Minn.–(BUSINESS WIRE)–AngioInsight, Inc., an innovator in medical imaging technologies, is pleased to announce the appointment of Scott Burger as its Chief Executive Officer (CEO). Scott brings over two decades of extensive leadership experience in the healthcare and medical technology sectors, positioning him perfectly to lead AngioInsight into its next […]
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
Southlake, TX, Dec. 16, 2024 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the second quarter fiscal 2025 ended October 31, 2024 and provided a business update.



